These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32035935)

  • 21. Measuring Infection Transmission in a Stochastic SIV Model with Infection Reintroduction and Imperfect Vaccine.
    Gamboa M; Lopez-Herrero MJ
    Acta Biotheor; 2020 Dec; 68(4):395-420. PubMed ID: 31916048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the Transmission Dynamics and Control of Mumps in Mainland China.
    Li Y; Liu X; Wang L
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29278378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and bifurcations in a discrete-time epidemic model with vaccination and vital dynamics.
    Parsamanesh M; Erfanian M; Mehrshad S
    BMC Bioinformatics; 2020 Nov; 21(1):525. PubMed ID: 33198622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles in developing countries. Part II. The predicted impact of mass vaccination.
    McLean AR; Anderson RM
    Epidemiol Infect; 1988 Jun; 100(3):419-42. PubMed ID: 3378585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of media converge on complex networks on disease transmission.
    Liu MX; He SS; Sun YZ
    Math Biosci Eng; 2019 Jul; 16(6):6335-6349. PubMed ID: 31698565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.
    Yang W; Li J; Shaman J
    PLoS Comput Biol; 2019 Feb; 15(2):e1006806. PubMed ID: 30716080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness and policy announcement: The case of measles mandatory vaccination.
    Flaig J; Houy N; Michel P
    J Theor Biol; 2020 Jan; 485():110028. PubMed ID: 31568787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimum attack rate for measuring measles vaccine efficacy.
    Nourjah P; Frerichs RR
    Int J Epidemiol; 1995 Aug; 24(4):834-41. PubMed ID: 8550283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis, treatment and prevention of measles].
    Lacroix L; Delaporte E; Siegrist CA; Sudre P; Wyler CA; Gervaix A
    Rev Med Suisse; 2008 Apr; 4(152):920-4. PubMed ID: 18578433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of SIR epidemic models with nonlinear incidence rate and treatment.
    Hu Z; Ma W; Ruan S
    Math Biosci; 2012 Jul; 238(1):12-20. PubMed ID: 22516532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictability in a highly stochastic system: final size of measles epidemics in small populations.
    Caudron Q; Mahmud AS; Metcalf CJ; Gottfreðsson M; Viboud C; Cliff AD; Grenfell BT
    J R Soc Interface; 2015 Jan; 12(102):20141125. PubMed ID: 25411411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Measles: from a simple rash - to a fatal outcome ?].
    Brix T; Guo C; Magnenat E; Béguelin C
    Rev Med Suisse; 2019 Oct; 15(666):1807-1811. PubMed ID: 31599522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming.
    Tanner MW; Sattenspiel L; Ntaimo L
    Math Biosci; 2008 Oct; 215(2):144-51. PubMed ID: 18700149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling and optimal control of pneumonia disease with cost-effective strategies.
    Tilahun GT; Makinde OD; Malonza D
    J Biol Dyn; 2017 Aug; 11(sup2):400-426. PubMed ID: 28613986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The social impact of the vaccination against measles in Mexico. Comments during the course of the epidemics of 1988-1990].
    Cárdenas-Ayala VM; Sánchez-Vargas C
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):500-5. PubMed ID: 2206416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on the stability behavior of an epidemic model with ratio-dependent incidence and saturated treatment.
    Kumar A; Kumar M; Nilam
    Theory Biosci; 2020 Jun; 139(2):225-234. PubMed ID: 32232649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.